Combining GLP-1 Drugs With Other Diabetes Medications
GLP-1 drugs are often prescribed alongside metformin, insulin, or SGLT2 inhibitors. Here's why combination therapy is common and what it requires monitoring for.
By the GLP Semaglutide editorial team · Last updated October 5, 2025
GLP-1 receptor agonists are frequently prescribed as an add-on to existing diabetes therapy rather than a replacement, particularly for patients who haven't reached blood sugar targets on metformin alone.
Insulin combinations need closer monitoring
Combining a GLP-1 drug with insulin or sulfonylureas raises the risk of hypoglycemia (low blood sugar), which is why prescribers often adjust insulin doses downward when adding a GLP-1 drug and monitor blood sugar more closely during the transition.
Not a decision to make solo
Adjusting or combining diabetes medications without medical supervision carries real risk. This overview describes common prescribing patterns, not a recommendation for any individual's regimen.
Primary sources